Oragenics Highlights Strategic Direction for 2012 in Corporate Video
Posted by: Admin
January 27th, 2012 >> Corporate
TAMPA, Fla.–(BUSINESS WIRE)–Florida-based nutraceutical company, Oragenics, Inc. (OTCQB: ORNI),
announced today that it has released a corporate video narrated by Chief
Executive Officer, John N. Bonfiglio, PhD on the 2012 strategic
direction for Oragenics. The video highlights how Oragenics is creating
value by leveraging the $32B probiotic market and addressing the renewed
focus on building a strong probiotic business for oral care. Bonfiglio’s
commentary also highlights Oragenics’ platform technology, ProBiora3®,
which was recognized by Frost amp; Sullivan in November 2011, and is the
active ingredient used in the Company’s oral care suite of products. Dr.
Bonfiglio explains how on the corporate side, the team will be executing
more on its business development and sales initiatives.
“Given the evolution and sophisticated science in the probiotics
marketplace, we feel that educating consumers, investors, and the
general public on ProBiora3® is essential. The video also shares
management’s vision for becoming the world leader in oral care
probiotics for humans and companion pets on a more detailed level. Given
the role oral care now plays in supporting overall health, the intent of
the video is to broaden the awareness of probiotics for oral care and to
share Oragenics vision going forward in 2012,” stated John N.
Bonfiglio, PhD
The video can be accessed on Oragenics’ corporate site www.oragenics.com
as well as Facebook, YouTube, and other informative news feeds.
About Oragenics, Inc.
Oragenics is a leading nutraceutical company focused on oral care
probiotics for humans and companion pets. The Companys proprietary
products Evora® and ProBiora3® are currently sold in over 20 countries.
In addition, Oragenics has a robust pipeline of therapeutic products
targeting infectious disease.
Safe Harbor Statement: Under the Private Securities Litigation
Reform Act of 1995: This release includes forward-looking statements
that reflect the Company’s current views with respect to future events
and financial performance. These forward-looking statements are based on
management’s beliefs and assumptions and information currently
available. The words “believe,” “expect,” “anticipate,” “intend,”
“estimate,” “project” and similar expressions that do not relate solely
to historical matters identify forward-looking statements. Investors
should be cautious in relying on forward-looking statements because they
are subject to a variety of risks, uncertainties, and other factors that
could cause actual results to differ materially from those expressed in
any such forward-looking statements. These factors include, but are not
limited to those set forth in our most recently filed annual report on
Form 10-K and quarterly report on Form 10-Q, and other factors detailed
from time to time in filings with the US Securities and Exchange
Commission. We expressly disclaim any responsibility to update
forward-looking statements.
For more information about ProBiora3®, visit www.oragenics.com.